Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Camargo Appoints Commercial Strategy VP | Contract Pharma
Breaking News, Promotions & Moves

Camargo Appoints Commercial Strategy VP

Rob Lawrence will lead the design and development of strategic solutions that aim to optimize patient access and outcomes.

Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, has appointed Robb Lawrence as Vice President of Commercial Strategy. In this senior leadership role, Lawrence will lead the design and development of strategic solutions that optimize patient access and outcomes by navigating the complexities of the global healthcare markets.

“Robb’s level of experience and his commitment to addressing unmet patient needs will be an enormous asset to our leadership team,” Camargo CEO Dan Duffy said. “We look forward to working with him in this newly created role to elevate the commercial solutions that Camargo offers our sponsors as they work to deliver therapies to patients.”

Lawrence brings 20 years of experience in pharmaceutical development, from both the product sponsor and the service provider perspectives. His career has focused on managing products’ commercialization strategies throughout the development life cycle. He most recently served as founder and CEO of TLC Therapeutics, LLC, and Tropical Disease Therapeutics, LLC, where he worked to advance niche reformulations of established medicines and neglected tropical diseases, respectively.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters